The most efficient route to antibodies with real functional activity vs. binders.
28 Oct 2024
Lead Identification & Optimization
- Functional screening vs binding assays.
- Engineering antibodies to enhance Fc-region-mediated effector functions.
- Combining In silico and in vivo models.
